Insulin glargine and lixisenatide Subcutaneous and Saw Palmetto
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Saw Palmetto and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: saw palmetto
Brand name: Prostate SR
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Saxagliptin
- Insulin glargine and lixisenatide Subcutaneous-Saxagliptin and dapagliflozin
- Insulin glargine and lixisenatide Subcutaneous-Saxagliptin and Metformin
- Insulin glargine and lixisenatide Subcutaneous-Saxagliptin Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Saxenda
- Insulin glargine and lixisenatide Subcutaneous-Scalacort
- Saw Palmetto-Insulin glargine, recombinant Subcutaneous
- Saw Palmetto-Insulin glulisine
- Saw Palmetto-Insulin Glulisine (Cartridges and Pens)
- Saw Palmetto-Insulin Glulisine (Vials)
- Saw Palmetto-Insulin glulisine Subcutaneous
- Saw Palmetto-Insulin human inhaled Inhalation